Status:
COMPLETED
The HF-HRV Registry
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Heart Failure
Arrhythmia
Eligibility:
All Genders
18+ years
Brief Summary
The Registry will evaluate how HRV Monitor diagnostics change after cardiac resynchronization therapy in patients with heart failure.
Eligibility Criteria
Inclusion
- Patients receiving their first CRT-D
- Patients who sign and date a Patient Informed Consent prior to device implant
- Patients who are available and willing to attend follow-up visits at the study center in which they were enrolled
Exclusion
- Patients who are anticipated to receive pacing modes other than DDD or VDD (i.e., chronic atrial fibrillation patients are excluded), or patients who are anticipated to receive adaptive rate therapy
- Patients who are younger than 18 years of age
- Patients whose life expectancy is less than six-months due to other medical conditions
- Patients with or who are likely to receive a tricuspid or other valve prosthesis
- Patients who are currently enrolled in another investigational study that would directly impact the treatment or outcome of the current study
- Women who are pregnant
Key Trial Info
Start Date :
February 1 2003
Trial Type :
OBSERVATIONAL
End Date :
May 1 2005
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT00236236
Start Date
February 1 2003
End Date
May 1 2005
Last Update
November 14 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.